What are the recommended treatment guidelines according to TRIPP (Tension-type Headache, Migraine, and Cluster Headache Treatment and Research Initiative for Pain and Palliative care) for managing symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TRIPP Guidelines for Managing Tension-type Headache, Migraine, and Cluster Headache

For acute migraine treatment, the recommended first-line approach is combination therapy with a triptan and an NSAID or acetaminophen, which provides superior pain relief compared to monotherapy. 1

Migraine Management

Acute Treatment

  • Begin with NSAIDs or acetaminophen for mild to moderate migraine attacks 1

    • Options include aspirin, ibuprofen, naproxen, or acetaminophen-aspirin-caffeine combination 1
    • Ensure adequate dosing before concluding treatment failure 1
  • For moderate to severe attacks or inadequate response to NSAIDs/acetaminophen:

    • Add a triptan (sumatriptan, rizatriptan, eletriptan, frovatriptan, zolmitriptan) to an NSAID or acetaminophen 1
    • The combination of a triptan with an NSAID provides superior pain freedom and sustained pain relief compared to monotherapy 1
  • For patients with inadequate response to triptan combinations:

    • Consider CGRP antagonists-gepants (rimegepant, ubrogepant, zavegepant) 1
    • Consider lasmiditan only if other treatments fail 1
  • For patients with severe nausea/vomiting:

    • Use non-oral routes of administration (subcutaneous, intranasal) 1
    • Add antiemetics to treat nausea even if not vomiting 1
  • Important cautions:

    • Do not use opioids or butalbital for acute migraine treatment 1
    • Begin treatment as soon as possible after migraine onset 1
    • Limit acute treatments to twice weekly to prevent medication overuse headache 1

Preventive Treatment

  • Consider prevention for patients with:

    • Two or more attacks per month with disability lasting 3+ days 1
    • Inadequate response to acute treatments 1
    • Use of acute medications more than twice weekly 1
    • Presence of uncommon migraine conditions (hemiplegic, prolonged aura) 1
  • First-line preventive options:

    • Beta-blockers (propranolol 80-240 mg/d, timolol 20-30 mg/d) 1
    • Amitriptyline (30-150 mg/d) 1
    • Divalproex sodium (500-1500 mg/d) or sodium valproate (800-1500 mg/d) 1
    • Atogepant for episodic migraine 1
    • OnabotulinumtoxinA for chronic migraine only 1
  • Do not use:

    • Gabapentin for migraine prevention 1
    • OnabotulinumtoxinA for episodic migraine 1

Tension-Type Headache Management

Acute Treatment

  • First-line treatment: Ibuprofen (400 mg) or acetaminophen (1000 mg) 1, 2
  • Over-the-counter analgesics are typically effective for episodic tension-type headache 2
  • Caution: Using pain relievers more than twice weekly increases risk of developing chronic daily headache 2

Preventive Treatment

  • Amitriptyline is recommended for prevention of chronic tension-type headache 1, 2
  • Avoid botulinum/neurotoxin injections for chronic tension-type headache prevention 1
  • Consider non-pharmacological approaches like biofeedback, relaxation training, and cognitive therapy for frequent tension-type headaches 2

Cluster Headache Management

Acute Treatment

  • First-line options:
    • Subcutaneous sumatriptan (6 mg) 1, 3
    • Intranasal zolmitriptan (10 mg) 1, 3
    • Normobaric oxygen therapy at flow rates of at least 12 L/min for 15 minutes 1, 3

Preventive Treatment

  • For episodic cluster headache:

    • Galcanezumab is recommended as first-line prophylactic treatment 1, 3
    • Evidence is strongest for galcanezumab among available preventive options 3
  • For chronic cluster headache:

    • Avoid galcanezumab 1
    • Insufficient evidence for verapamil in both episodic and chronic cluster headache 1

Medication Overuse Headache

  • Define as headache occurring on 15+ days per month for at least 3 months due to overuse of acute medication 1
  • Threshold for medication overuse varies by treatment type 1
  • Insufficient evidence for specific preventive agents or withdrawal strategies 1
  • Patient education about medication overuse is essential 1

Monitoring and Follow-up

  • Track headache frequency, severity, duration, disability, treatment response, and adverse effects using daily flow sheets or diaries 1
  • Identify and avoid headache triggers (alcohol, caffeine, certain foods, stress, fatigue, strong smells) 1, 3
  • Counsel patients to begin treatment as early as possible in the headache attack 1
  • Consider adding preventive medications if episodic headaches occur frequently or acute treatments don't provide adequate response 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tension-type headache.

American family physician, 2002

Guideline

First-Line Prophylactic Treatment for Cluster Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.